Over the last year and a half, the fatal Covid-19 pandemic, which has yet to be identified as to where it originated and how it spread, has claimed countless lives, while mutating species have emerged in the UK, Brazil, India, and California.
As a result of the worldwide spread of this illness, financial transactions have been interrupted, prompting all governments to vigorously fight the pandemic.
According to recent World Health Organization (WHO) estimates, the Covid-19 virus infected 173 million 725 thousand 873 persons, resulting in 3 million 736 thousand 367 fatalities and a substantial number of patients suffering from Coronavirus-related complications.
Vaccines from the United Kingdom, the United States, China, Russia, India, and Kazakhstan have all been granted licenses for emergency use so far.
Meanwhile, according to Iran’s Ministry of Health and Medical Education’s Public Relations Center, the total number of Covid-19 patients in Iran has reached 2,971,270.
Today, experts and researchers from all around the globe, including Iran, are working diligently to produce effective vaccinations, giving the public hope.
Despite severe sanctions, particularly those targeting its medical sector, Iran is one of the few countries that has achieved the technology required to make Coronavirus vaccines.
Iran-Barakat is one of five Iranian companies attempting to get the requisite certificates from Iranian medical authorities to mass-produce and distribute domestically manufactured vaccines.
Iran’s spectacular achievements have inspired hope in other countries, including two European countries that have asked Tehran to sell Covid-19 vaccines.
While many countries have been waiting for Covid-19 vaccines developed by outstanding western pharmaceutical corporations, Iran, Cuba, and Nigeria are determined in relying on their scientists.
“Despite US sanctions, Iran, which is currently grappling with the fourth wave of the Covid-19 pandemic, is determined to rely on its vast medical capabilities”, according to the French daily La Croix.